Published in J Manag Care Pharm on December 10, 2003
Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol (2009) 1.71
Practitioners' views on computerized drug-drug interaction alerts in the VA system. J Am Med Inform Assoc (2006) 1.60
Pharmacy students' retention of knowledge of drug-drug interactions. Am J Pharm Educ (2011) 1.11
Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc (2007) 1.10
Study of drug-drug interactions in prescriptions of general practitioners and specialists in iran 2007-2009. Iran J Pharm Res (2011) 1.08
Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol (2014) 0.89
Prevalence of the prescription of potentially interacting drugs. PLoS One (2013) 0.87
Pharmacy students' ability to identify potential drug-drug interactions. Am J Pharm Educ (2009) 0.82
Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland. Eur J Clin Pharmacol (2007) 0.82
The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc (2007) 0.78
Prevalence of adverse drug combinations in a large post-mortem toxicology database. Int J Legal Med (2008) 0.77
Detection of potential drug-drug interactions for outpatients across hospitals. Int J Environ Res Public Health (2014) 0.75
The prevalence of major potential drug-drug interactions at a University health centre pharmacy in Jamaica. Pharm Pract (Granada) (2015) 0.75
Out-patients Prescriptions are Safe from Drug Interactions or Not: A Pilot Study Report. Indian J Pharm Sci (2011) 0.75
Relationship between drug interactions and drug-related negative clinical outcomes. Pharm Pract (Granada) (2009) 0.75
Prevalence and Correlates of Drug-drug Interactions in the Regional Hospital of Gjilan, Kosovo. Mater Sociomed (2014) 0.75
Evaluation of a drug-drug interaction: fax alert intervention program. BMC Med Inform Decis Mak (2013) 0.75
An evaluation of the completeness of drug-drug interaction-related information in package inserts. Eur J Clin Pharmacol (2016) 0.75
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Rate and predictors of treatment prescription for hepatitis C. Gut (2006) 2.31
Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003. Am J Manag Care (2005) 2.08
Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual (2005) 1.73
Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures. Am Heart J (2007) 1.69
Systematic review: comparison of the quality of medical care in Veterans Affairs and non-Veterans Affairs settings. Med Care (2011) 1.63
Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care. J Gen Intern Med (2005) 1.48
Comparisons of quality of surgical care between the US Department of Veterans Affairs and the private sector. J Am Coll Surg (2010) 1.47
How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry (2005) 1.46
Perceptions of standards-based electronic prescribing systems as implemented in outpatient primary care: a physician survey. J Am Med Inform Assoc (2009) 1.45
Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. Am J Kidney Dis (2012) 1.44
Adherence to hormonal contraception among women veterans: differences by race/ethnicity and contraceptive supply. Am J Obstet Gynecol (2013) 1.43
Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord (2007) 1.29
Racial differences in adherence to cardiac medications. J Natl Med Assoc (2003) 1.28
Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med (2004) 1.14
Access to affordable medications: the Department of Veterans Affairs pharmacy plan as a national model. Am J Public Health (2007) 1.13
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. J Affect Disord (2007) 1.11
Use of antipsychotics among older residents in VA nursing homes. Med Care (2012) 1.06
The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs. Med Care (2005) 1.03
The accuracy of clinician perceptions of "usual" blood pressure control. J Gen Intern Med (2007) 1.01
Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Ann Intern Med (2013) 1.01
Does screening for pain correspond to high quality care for veterans? J Gen Intern Med (2010) 1.01
Racial differences in the treatment of veterans with bipolar disorder. Psychiatr Serv (2005) 1.00
Antibiotic prescribing for presumed nonbacterial acute respiratory tract infections. Am J Emerg Med (2009) 1.00
Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System. Am J Manag Care (2010) 1.00
Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital. Am J Health Syst Pharm (2002) 1.00
Provision of potentially teratogenic medications to female veterans of childbearing age. Med Care (2010) 0.99
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging (2013) 0.96
Delay in presentation for cardiac care by race, age, and site of care. Med Care (2002) 0.95
Macitentan and pulmonary arterial hypertension. N Engl J Med (2014) 0.92
Facility-level variation in potentially inappropriate prescribing for older veterans. J Am Geriatr Soc (2012) 0.90
Trends in use of high-risk medications for older veterans: 2004 to 2006. J Am Geriatr Soc (2011) 0.88
Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol (2007) 0.88
Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Ther (2008) 0.87
Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. Am J Cardiol (2007) 0.87
Monitoring adverse drug reactions across a nationwide health care system using information technology. Am J Health Syst Pharm (2012) 0.86
Effect of hyponatremia (<135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol (2007) 0.86
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients. Am J Public Health (2007) 0.85
Perioperative risk of noncardiac surgery associated with aortic stenosis. Am J Cardiol (2005) 0.84
Potential safety gaps in order entry and automated drug alerts: a nationwide survey of VA physician self-reported practices with computerized order entry. Med Care (2011) 0.84
Intervention to decrease glyburide use in elderly patients with renal insufficiency. Am J Geriatr Pharmacother (2011) 0.83
Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones. J Manag Care Pharm (2008) 0.82
National utilization of antihypertensive medications from 2000 to 2006 in the Veterans Health Administration: focus on thiazide diuretics. J Clin Hypertens (Greenwich) (2008) 0.82
FDA warning and removal of rosiglitazone from VA national formulary. Am J Manag Care (2013) 0.81
Severe dysglycemia with the fluoroquinolones: a class effect? Clin Infect Dis (2009) 0.81
Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis. South Med J (2003) 0.81
Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most? Am J Manag Care (2004) 0.80
Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome. Am J Cardiol (2009) 0.80
Determinants of complementary and alternative medicine use by patients with bipolar disorder. Psychopharmacol Bull (2007) 0.78
Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study. BMC Geriatr (2015) 0.78
Prescription drug samples: making decisions with imperfect data. J Gen Intern Med (2008) 0.78
Determinants of hormone therapy discontinuation among female veterans nationally. Mil Med (2008) 0.78
Algorithm for assessing patients' adherence to oral hypoglycemic medication. Am J Health Syst Pharm (2005) 0.77
An ethical framework for pharmacy management: balancing autonomy and other principles. J Manag Care Spec Pharm (2014) 0.77
Lansoprazole overutilization: methods for step-down therapy. Am J Manag Care (2003) 0.77
Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011. Am J Manag Care (2014) 0.76
Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy. Clin Cardiol (2006) 0.76
Effect of both elevated troponin-I and peripheral white blood cell count on prognosis in patients with suspected myocardial injury. Am J Cardiol (2005) 0.75
Target blood pressure and kidney disease. Ann Intern Med (2005) 0.75
Varicella-zoster vaccine. N Engl J Med (2007) 0.75
Glycemic control was unchanged in Veterans Health Administration patients converted from glyburide to glipizide. J Manag Care Pharm (2012) 0.75
Spiraling drug costs: a call for cost-effective prescribing. J Am Geriatr Soc (2005) 0.75
Cost-effectiveness of blood glucose monitoring is controversial. Am J Manag Care (2008) 0.75
The Vioxx debacle revisited. Am J Med (2005) 0.75
Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium. Ann Intern Med (2006) 0.75
Bending the cost curve in cancer care. N Engl J Med (2011) 0.75
Adapting Cognitive Task Analysis to Investigate Clinical Decision Making and Medication Safety Incidents. J Patient Saf (2017) 0.75
Pharmacy Use in the First Year of the Veterans Choice Program: A Mixed-Methods Evaluation. Med Care (2017) 0.75
Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers. Oncol Res (2015) 0.75
Medication-use evaluation with a Web application. Am J Health Syst Pharm (2013) 0.75
Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients. Appl Health Econ Health Policy (2013) 0.75
Incremental cost-effectiveness of various monthly doses of vardenafil. Value Health (2011) 0.75
VA pharmacy users: how they differ from other veterans. Am J Manag Care (2009) 0.75
CRP & cardiovascular disease. Measuring C-reactive protein can help assess a patient's CVD risk. Adv NPs PAs (2011) 0.75